OP
友霖生技醫藥股份有限公司
OP is a Taiwan TPEx-listed biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| 1PL105 | — | — | — | — | 2026-06-10 | Company disclosure |
| Methydur | — | — | — | — | 2025-07-29 | Company disclosure |
| Tonvasca | — | — | — | — | 2025-07-29 | Company disclosure |
Key events
- Business update (company filing)
Related Drugnews articles
No related articles in this language.